At the beginning of March, we had the opportunity to visit Medical Japan 2026. It was a short but highly meaningful trip. During our time in Japan, we connected with a wide range of innovators, industry professionals, and potential partners 🤝. Through these conversations, we exchanged ideas, explored different perspectives, and gained valuable insights into how healthcare solutions are evolving across different markets. We also had the chance to engage with local experts,

On February 11, we were honored to present at the Healthcare Conference Taipei 2026 hosted by J.P. Morgan and UC Berkeley at The Regent Taipei. Compared to our last presentation, we have achieved important milestones 🚀, expanded our clinical footprint, and made significant progress in strengthening our bioadhesive technology. 💪 Thanks to the UC Berkeley School of Public Health for the opportunity. And thank you to everyone we had the pleasure of meeting. 😊

💪 We're honored to share that MoleculeX has been ranked 13 Biotech Company in Taiwan on F6S this January 2026. Compared to last year, we've reached several important milestones. More hospitals in Taiwan have adopted our Oral Wound Dressing, and we received our second TFDA medical device license for our new product, MuCoat. Beyond this, multiple new products in our pipeline are actively under development, and we are preparing to bring them to market this year. Step by step, w

In this cold season ☃️ , we sincerely hope everyone is doing well and enjoying a warm and joyful Christmas. As we reach the end of 2025, it feels like the perfect moment to reflect on the milestones that shaped our year. ✨ 2025 Highlights ✨ 🚀 At the beginning of the year, we joined the X. health Japan program, led by Encognize G.K. and xCARE. With the support of this program, we clarified our Japan market entry strategy and had the opportunity to meet many partners during J

Radiotherapy for head and neck cancer, whether photon, proton, or heavy-ion, often triggers severe oral mucositis. These painful ulcers can force patients to reduce dose, stretch treatment intervals, or even interrupt therapy, compromising outcomes and quality of life.🥲 🚀 On Nov 6, our team visited Yuan's General Hospital (阮綜合醫院) in Kaohsiung to introduce MuCover Oral Wound Dressing. We are deeply grateful to the physicians, nurses, and allied health professionals who shar

🎃 Trick or treat? 🍬 🎉 This Halloween feels extra special — we’ve just reached 100 followers on our LinkedIn page! Thank you for your support, we’ll keep moving forward to make oral care better every day. ❤️ While everyone is enjoying candies and sweets, don’t forget to give your mouth some love too! Meet Oral Patch-it Intra-Oral Patch (口K繃) , our daily solution designed to make oral wellness simple and gentle. With ultra-thin comfort , herbal extracts , and a biodegradabl

🏥 Over the past few weeks, we have kept visiting hospitals across Taiwan, sharing our clinical experience and listening to valuable feedback from healthcare professionals. 🟨 During these visits, we introduced MuCover Oral Wound Dressing (口合貼) , a medical-grade intra-oral patch designed to protect and soothe oral wounds, especially those caused by cancer treatments. MuCover acts like a gentle layer of artificial skin, made with biocompatible materials that adhere softly to

From August 8–10, right over Father's Day weekend, MoleculeX had the pleasure of joining the Healthy Ageing Tech Show 2025 at the Taipei World Trade Center. 💙 First of all, Happy Father's Day to all the incredible dads out there! 👨‍👧‍👦 We are truly grateful to everyone who visited our booth and joined our mini activity, and it was such a joy meeting so many people interested in our Intra Oral Patch, a little helper designed for daily oral care. We hope it will become par

On June 24, we finally met our amazing consultant partners encognize G.K. team in person! Thank you for your warm hospitality and the strategic insights you shared with us during the X. HEALTH Japan program. Your guidance has given us a solid foundation for our next steps in the Japanese market. Our next stop: Japan Health 2025! 🚀 We had the incredible opportunity to meet innovators and partners from all over the world, exchanging ideas, products, and visions for the differe

💪 We're honored to share that MoleculeX has been ranked #7 Biotech Company in Taiwan on  F6S  this May 2025! From a small idea of helping people eat and live better through oral mucosa innovation, to being known among biotech startups, we're grateful for every step of the journey. 🙏 Thank you to everyone who has supported us. We still have a long way to go, and we hope to keep improving and growing as we bring better solutions to patients who need. 🔗 Check it out:  https:/